GLP-1 Agonists in Alcohol Use Disorder Research
Diabetes drugs show promise against cravings by targeting alcohol's reward pathways.
Ezra Sabatini
Features Editor
Ezra Sabatini is a features editor at glpletter covering emerging glp-1 indications. Based in San Francisco, Ezra has written for glpletter since 2020.
1 story · San Francisco
Diabetes drugs show promise against cravings by targeting alcohol's reward pathways.